Salim Bhaloo, DO
Otolaryngology · Granbury, TXNPI 1881672285
Payments from drug & device makers
Across 280 payments — averaging $71.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- Stryker$4K
- Intersect ENT, Inc.$4K
- Aerin Medical Inc.$3K
- Acclarent, Inc$661
- GSK$596
- plus $3K from 26 others
What the payments were for
- Consulting fees$8124%
- Travel & lodging$4,46722%
- Food & beverage$14,70773%
- Education$710%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 47 | $5,862 |
| Stryker | 42 | $3,611 |
| Intersect ENT, Inc. | 17 | $3,582 |
| Aerin Medical Inc. | 21 | $2,585 |
| Acclarent, Inc | 15 | $661 |
| GSK | 25 | $596 |
| Regeneron Healthcare Solutions, Inc. | 23 | $570 |
| Optinose US, Inc. | 27 | $475 |
| Integra Lifesciences Corporation | 5 | $290 |
| Chitogel Limited | 2 | $282 |
| Inspire Medical Systems, Inc. | 6 | $156 |
| AstraZeneca | 6 | $148 |
| Olympus America Inc. | 3 | $148 |
| Blueprint Medicines Corporation | 6 | $130 |
| Baudax Bio Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $112 |
| Johnson & Johnson | 1 | $87 |
| Xoran Technologies LLC | 1 | $75 |
| Smith+Nephew | 3 | $71 |
| Hikma Pharmaceuticals USA | 4 | $67 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $64 |
| Sanofi | 3 | $61 |
| Sanofi-aventis U.S. LLC | 1 | $53 |
| Amgen | 2 | $37 |
| Med-el Corporation | 1 | $35 |
| Merck | 2 | $32 |
| Genentech USA, Inc. | 2 | $32 |
| Phadia US Inc. | 2 | $30 |
| Alk-abello, Inc | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Baxter Healthcare | 1 | $19 |
| Philips North America LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROPEL$6,173
- SINUVA$3,836
- VIVAER STYLUS$1,340
- XPRESS ENT DILATION SYSTEM$1,270
- SCOPIS ENT$1,215
- RHINAER STYLUS$1,100
- STEALTHSTATION S8 PLATFORM$939
- TruDi Nav Cable$287
- Chitogel Endoscopic Sinus Surgery Kit$228
- FIAGON NAVIGATION UNIT$193
- LATERA$165
- Acclarent Aera$163
- Inspira Air$163
- RELIEVA SPINPLUS NAV$163
- TruDi Probe$163
- SPIROX - LATERA$139
- HYDRODEBRIDER$139
- ANJESO$125
- Olympus Capital Accessories$119
How this compares
$20,057 in reported general payments places this provider in the 90th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 368 | $10,670 |
| Montelukast Sodium | 890 | $7,250 |
| Epinephrine | 33 | $5,392 |
| RyaltrisOlopatadine Hcl/Mometasone | 17 | $4,591 |
| Azelastine Hcl | 143 | $4,179 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 21 | $3,088 |
| Pantoprazole Sodium | 293 | $2,216 |
| Ofloxacin | 65 | $1,423 |
| Levocetirizine Dihydrochloride | 127 | $1,295 |
| Fluticasone Propionate | 74 | $1,253 |
| Wixela InhubFluticasone Propion/Salmeterol | 12 | $1,170 |
| Famotidine | 69 | $921 |
| Methylprednisolone | 143 | $892 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 60 | $692 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 87 | $601 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USAEpinephrine, Ryaltris | $67 | $9,98350 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 729 otolaryngology providers in Texas.
Other otolaryngology in Granbury
- Laurence ChuAustin$37.4M
- Mark ZafereoHouston$7.8M
- Neil GrossHouston$1.5M
- Chad McDuffieFrisco$1.5M
- Ian AlexanderBoerne$999K
- Stephen LaiHouston$968K
- Benjamin CilentoSpring$963K
- Amber LuongHouston$793K
- Jeffrey RosenbloomSan Antonio$720K
- Masayoshi TakashimaHouston$644K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.